Jake Sherman of Punchbowl News reports that House Republicans are eyeing a package to extend government funding for three months and suspend the debt limit until January 2027. The bill has health extenders with no pharmacy benefit manager reform, according to Sherman. The three dominant PBMs are Cigna’s (CI) Express Scripts, CVS Caremark (CVS), and UnitedHealth’s (UNH) Optum Rx.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Trump Trade: Analyst says Trump win ‘not as positive as you’d think’ for Tesla
- Early notable gainers among liquid option names on December 18th
- PBMs took payments from manufacturers to allow free flow of opioids, NYT reports
- Trump Slams “Horrible Middlemen” and Sends CVS, UNH, & CI Stocks Tumbling
- Barclays fact-checked Trump comments on pharmacy benefit managers